CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 33.44
-0.12 (-0.36%)
Feb 13, 2026, 4:08 PM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 12.71 billion as of February 13, 2026. Its market cap has increased by 19.36% in one year.
Market Cap
12.71B
Enterprise Value
11.21B
Revenue
1.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
33.44
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 12.71B, an increase of 67.82%. That is a compound annual growth rate of 7.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 12.85B | 1.73% |
| Dec 31, 2025 | 12.63B | 8.81% |
| Dec 31, 2024 | 11.61B | -7.23% |
| Dec 29, 2023 | 12.51B | -54.81% |
| Dec 30, 2022 | 27.69B | -58.12% |
| Dec 31, 2021 | 66.11B | -11.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ab&B Bio-Tech CO., LTD. JS | 19.49B |
| Consun Pharmaceutical Group | 15.33B |
| Sihuan Pharmaceutical Holdings Group | 15.16B |
| CF PharmTech | 14.65B |
| Luye Pharma Group | 10.94B |
| Shandong Xinhua Pharmaceutical Company | 10.38B |
| China Traditional Chinese Medicine Holdings Co. | 10.37B |
| SSY Group | 8.81B |